Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | -0.0065 | 0.9 |
mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.9 |
mRNA | temsirolimus | FIMM | pan-cancer | AAC | 0.029 | 0.9 |
mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.9 |
mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.0053 | 0.9 |
mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | -0.0059 | 0.9 |
mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | -0.0056 | 0.9 |
mRNA | Crizotinib | FIMM | pan-cancer | AAC | -0.031 | 0.9 |
mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | 0.0051 | 0.9 |
mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | -0.0061 | 0.9 |